Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty

R. Abbate, R. Marcucci, O. Camacho-Vanegas, G. Pepe, A. M. Gori, M. Capanni, I. Simonetti, D. Prisco, G. F. Gensini

Research output: Contribution to journalArticle

Abstract

This study suggests a macroheterogeneity in prevalence of platelet glycoprotein PL(A1/A2) polymorphism in different ethnic populations. In patients undergoing percutaneous transluminal coronary angioplasty, this polymorphism does not represent an independent risk factor but seems to be implicated in restenosis after percutaneous transluminal coronary angioplasty.

Original languageEnglish
Pages (from-to)524-525
Number of pages2
JournalThe American Journal of Cardiology
Volume82
Issue number4
DOIs
Publication statusPublished - 1998

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty'. Together they form a unique fingerprint.

  • Cite this

    Abbate, R., Marcucci, R., Camacho-Vanegas, O., Pepe, G., Gori, A. M., Capanni, M., Simonetti, I., Prisco, D., & Gensini, G. F. (1998). Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty. The American Journal of Cardiology, 82(4), 524-525. https://doi.org/10.1016/S0002-9149(98)00379-8